Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the production of active pharmaceutical ingredients (APIs) requiring high enantiomeric purity. Its structure supports the development of bioactive molecules, especially in central nervous system (CNS) agents and receptor modulators. Commonly employed in asymmetric synthesis due to the stability of the tert-butyl carbamate (Boc) protecting group and the defined stereochemistry, enabling selective reactions in multi-step drug manufacturing processes.